{
    "applicationNumber": "BR 11 2022 022030-8",
    "filingDate": "01/06/2021",
    "grantDate": null,
    "title": "ANTICORPO HUMANIZADO DO RECEPTOR ANTI-IGF-1, MOL\u00c9CULA DE \u00c1CIDO NUCLEICO, VETOR DE CLONAGEM OU VETOR DE EXPRESS\u00c3O, C\u00c9LULA RECOMBINANTE, PROCESSO PARA PRODUZIR UM ANTICORPO HUMANIZADO DO RECEPTOR ANTI-IGF-1, E, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA",
    "nationalPhaseDate": [
        "28/10/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT JP2021/020890",
        "pctDate": "01/06/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "JP",
            "priorityNumber": "2020-096344",
            "priorityDate": "02/06/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2705"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2713"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2715"
        }
    ],
    "inventors": [
        "HIROAKI MATSUKAWA",
        "HIROSHI EGUCHI",
        "NAOKO NAMIKI",
        "AKIRA TANOKURA"
    ],
    "holders": [
        109017
    ],
    "ipcCodes": [
        "C12N 15/63",
        "A61P 35/00",
        "A61K 39/395",
        "A61K 48/00",
        "C12N 5/10",
        "C12N 1/21",
        "C12N 1/15",
        "C12P 21/08",
        "A61P 21/00",
        "C12N 1/19",
        "C07K 16/46",
        "C07K 16/28",
        "C12N 15/13",
        "A61K 31/7088"
    ]
}